Patents by Inventor Manuel Allue

Manuel Allue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds For The Treatment Of An Acute Injury To The Central Nervous System
    Publication number: 20070203239
    Abstract: KATP channel closers (KCCs) are useful for the prophylactic and/or therapeutic treatment of a CNS acute damage in a mammal, including a human, because their administration, particularly in the case of glibenclamide, potientates the neuroprotector microglial effect. Therefore, they may be useful in treating the acute phase of CNS diseases such as stroke, seizure, axonal injury, traumatic damage, neurodegeneration, spinal cord injury, infectious and autoimmune CNS diseases. KCCs, isotopically modified, are also useful for the preparation of diagnostic agents for detection and follow-up of CNS acute damage.
    Type: Application
    Filed: June 23, 2005
    Publication date: August 30, 2007
    Applicant: Neurotec Pharma, S.L.
    Inventors: Josette-Nicole Gehenne, Manuel Allue, Marco Pugliese